Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 11/20 | 0.41 |
| ▸ | LIPG | Q9Y5X9 | 11/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | RXRA | P19793 | 3/20 | 0.35 |
| ▸ | RXRB | P28702 | 3/20 | 0.35 |
| ▸ | RXRG | P48443 | 2/20 | 0.35 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23909384 | 1.00 | LPL (0.41) | LPLLIPGFFAR1HIF1ARXRA | |
| SCHEMBL23928352 | 0.98 | LPL (0.40) | LPLLIPGFFAR1HIF1ARXRA | |
| SCHEMBL15590689 | 0.96 | LPL (0.41) | LPLLIPGFFAR1HIF1ARXRA | |
| SCHEMBL12205425 | 0.93 | LPL (0.41) | LPLLIPGFFAR1HIF1ANR1I2 | |
| SCHEMBL19766312 | 0.89 | LPL (0.36) | LPLLIPGFFAR1HIF1ARXRA | |
| SCHEMBL17350120 | 0.89 | LPL (0.41) | LPLLIPGFFAR1HIF1ANR1I2 | |
| SCHEMBL23909383 | 0.86 | LIPG (0.59) | LPLLIPGHIF1ARXRARXRB | |
| SCHEMBL23928043 | 0.85 | LIPG (0.46) | LPLLIPGFFAR1HIF1ARXRA | |
| SCHEMBL13468746 | 0.84 | FFAR1 (0.41) | LPLLIPGFFAR1HIF1ANR1I2 | |
| SCHEMBL13468810 | 0.84 | LPL (0.39) | LPLLIPGFFAR1HIF1ANR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250115544-A1 | ARYLAMINE COMPOUND, HOLE-TRANSPORT LAYER MATERIAL, HOLE-INJECTION LAYER MATERIAL, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC APPARATUS, AND LIGHTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2025-04-10 | — | — | US | disclosed |
| CN-115132935-A | Light-emitting device, display device, light-emitting device, electronic apparatus, and lighting device | 株式会社半导体能源研究所 | 2022-09-30 | — | — | CN | disclosed |
| CN-114975808-A | Light-emitting device, display device, light-emitting device, electronic apparatus, and lighting device | 株式会社半导体能源研究所 | 2022-08-30 | — | — | CN | disclosed |
| CN-114695776-A | Organic semiconductor device, organic EL device, photodiode sensor, display device, light-emitting device, and electronic apparatus | 株式会社半导体能源研究所 | 2022-07-01 | — | — | CN | disclosed |
| CN-114141972-A | Light-emitting device, light-emitting apparatus, electronic apparatus, and lighting apparatus | 株式会社半导体能源研究所 | 2022-03-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250115544-A1 | ARYLAMINE COMPOUND, HOLE-TRANSPORT LAYER MATERIAL, HOLE-INJECTION LAYER MATERIAL, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC APPARATUS, AND LIGHTING DEVICE | AHR, ARNT, AAAS | LPL 1561/4885LIPG 2793/4885FFAR1 3766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.